Home page
#1 Brand names


Sites parents
Brand name

Information about GlaxoSmithKline brand name. This is a page presenting information about GlaxoSmithKline brand name on Visiobrand - the biggest brand directory in the Internet. Visiobrand has selected GlaxoSmithKline brand name and registered GlaxoSmithKline links manually in its directory. All the information about GlaxoSmithKline presented on the Visiobrand site is only verified information from the official GlaxoSmithKline source.

This is the VisioBrand's cache of http://www.gsk.com/responsibility/index.htm. The page may have been changed since the time we've created the cache.
Click here for the current version of the page.

Please also find related categories of brand names on VisioBrand catalogue:
Personal (1054)
Health, Medical (223)
Feminine Protection (20)
Membership
VisioBrand has a free membership account where you can take advantages of special services such as adding GlaxoSmithKline brand name to your favourite brands list to be able to quickly find them and learn what’s new.

Submit information on GlaxoSmithKline If you want us to feature some special links to GlaxoSmithKline official site, please contact us.

VisioBrand - Official Site - GlaxoSmithKline
  • Home
  • About us
  • Our products
  • Your health
  • Responsibility
  • In the community
  • Research & development
  • Investors
  • Media centre
  • Careers
Advanced search

Responsibility

Welcome to the corporate responsibility section. In this section you will find information on the values and policies that guide our business and also our annual corporate responsibility report.


 
Image of GSK CR Report 2005

View the 2005 CR Report online

Image of a compass

Our values and policies

Image of a wind turbine
Read our new positions on environmental issues:
*
*
Responsibility highlights
Over 12,000 managers certified their compliance with the Code of conduct
126 million Combivir and Epivir tablets supplied to developing countries at preferential prices
Quick Links
*
Image of family

Access to medicines

Millions of poor people in both developed and developing countries cannot obtain the medicines they need. This is part of a broader problem of access to healthcare which remains a significant challenge in many parts of the world. The primary responsibility for addressing this problem rests with governments, but all stakeholders, including the pharmaceutical industry, have important contributions to make.

Case studies

These case studies show our corporate responsibility programmes in action during 2005.

 
*
Image of a tree
Image of a woman walking

Clinical trials
Find out more about our clinical trials